List of Tables
Table 1. Global Hyperammonemia Medication Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Glycerol Phenylbutyrate
Table 3. Key Players of Sodium Phenylbutyrate
Table 4. Global Hyperammonemia Medication Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Hyperammonemia Medication Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Hyperammonemia Medication Market Size by Region (US$ Million), 2021–2026
Table 7. Global Hyperammonemia Medication Market Share by Region (2021–2026)
Table 8. Global Hyperammonemia Medication Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Hyperammonemia Medication Market Share by Region (2027–2032)
Table 10. Hyperammonemia Medication Market Trends
Table 11. Hyperammonemia Medication Market Drivers
Table 12. Hyperammonemia Medication Market Challenges
Table 13. Hyperammonemia Medication Market Restraints
Table 14. Global Hyperammonemia Medication Revenue by Players (US$ Million), 2021–2026
Table 15. Global Hyperammonemia Medication Market Share by Players (2021–2026)
Table 16. Global Top Hyperammonemia Medication Players by Tier (Tier 1, Tier 2, and Tier 3), based on Hyperammonemia Medication Revenue, 2025
Table 17. Ranking of Global Top Hyperammonemia Medication Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Hyperammonemia Medication Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Hyperammonemia Medication, Headquarters and Area Served
Table 20. Global Key Players of Hyperammonemia Medication, Products and Applications
Table 21. Global Key Players of Hyperammonemia Medication, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Hyperammonemia Medication Market Size by Type (US$ Million), 2021–2026
Table 24. Global Hyperammonemia Medication Revenue Market Share by Type (2021–2026)
Table 25. Global Hyperammonemia Medication Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Hyperammonemia Medication Revenue Market Share by Type (2027–2032)
Table 27. Global Hyperammonemia Medication Market Size by Application (US$ Million), 2021–2026
Table 28. Global Hyperammonemia Medication Revenue Market Share by Application (2021–2026)
Table 29. Global Hyperammonemia Medication Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Hyperammonemia Medication Revenue Market Share by Application (2027–2032)
Table 31. North America Hyperammonemia Medication Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Hyperammonemia Medication Market Size by Country (US$ Million), 2021–2026
Table 33. North America Hyperammonemia Medication Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Hyperammonemia Medication Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Hyperammonemia Medication Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Hyperammonemia Medication Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Hyperammonemia Medication Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Hyperammonemia Medication Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Hyperammonemia Medication Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Hyperammonemia Medication Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Hyperammonemia Medication Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Hyperammonemia Medication Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Hyperammonemia Medication Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Hyperammonemia Medication Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Hyperammonemia Medication Market Size by Country (US$ Million), 2027–2032
Table 46. Horizon Pharma Company Details
Table 47. Horizon Pharma Business Overview
Table 48. Horizon Pharma Hyperammonemia Medication Product
Table 49. Horizon Pharma Revenue in Hyperammonemia Medication Business (US$ Million), 2021–2026
Table 50. Horizon Pharma Recent Development
Table 51. Lee's Pharmaceutical Company Details
Table 52. Lee's Pharmaceutical Business Overview
Table 53. Lee's Pharmaceutical Hyperammonemia Medication Product
Table 54. Lee's Pharmaceutical Revenue in Hyperammonemia Medication Business (US$ Million), 2021–2026
Table 55. Lee's Pharmaceutical Recent Development
Table 56. Medunik Company Details
Table 57. Medunik Business Overview
Table 58. Medunik Hyperammonemia Medication Product
Table 59. Medunik Revenue in Hyperammonemia Medication Business (US$ Million), 2021–2026
Table 60. Medunik Recent Development
Table 61. Sigmapharm Laboratories Company Details
Table 62. Sigmapharm Laboratories Business Overview
Table 63. Sigmapharm Laboratories Hyperammonemia Medication Product
Table 64. Sigmapharm Laboratories Revenue in Hyperammonemia Medication Business (US$ Million), 2021–2026
Table 65. Sigmapharm Laboratories Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Hyperammonemia Medication Product
Table 69. Amgen Revenue in Hyperammonemia Medication Business (US$ Million), 2021–2026
Table 70. Amgen Recent Development
Table 71. Acer Therapeutics Company Details
Table 72. Acer Therapeutics Business Overview
Table 73. Acer Therapeutics Hyperammonemia Medication Product
Table 74. Acer Therapeutics Revenue in Hyperammonemia Medication Business (US$ Million), 2021–2026
Table 75. Acer Therapeutics Recent Development
Table 76. Immedica Company Details
Table 77. Immedica Business Overview
Table 78. Immedica Hyperammonemia Medication Product
Table 79. Immedica Revenue in Hyperammonemia Medication Business (US$ Million), 2021–2026
Table 80. Immedica Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 84. Authors List of This Report
List of Figures
Figure 1. Hyperammonemia Medication Picture
Figure 2. Global Hyperammonemia Medication Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Hyperammonemia Medication Market Share by Type: 2025 vs 2032
Figure 4. Glycerol Phenylbutyrate Features
Figure 5. Sodium Phenylbutyrate Features
Figure 6. Global Hyperammonemia Medication Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Hyperammonemia Medication Market Share by Application: 2025 vs 2032
Figure 8. Hospital Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Hyperammonemia Medication Report Years Considered
Figure 11. Global Hyperammonemia Medication Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Hyperammonemia Medication Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Hyperammonemia Medication Market Share by Region: 2025 vs 2032
Figure 14. Global Hyperammonemia Medication Market Share by Players in 2025
Figure 15. Global Hyperammonemia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Hyperammonemia Medication Revenue in 2025
Figure 17. North America Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Hyperammonemia Medication Market Share by Country (2021–2032)
Figure 19. United States Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Hyperammonemia Medication Market Share by Country (2021–2032)
Figure 23. Germany Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Hyperammonemia Medication Market Share by Region (2021–2032)
Figure 31. China Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Hyperammonemia Medication Market Share by Country (2021–2032)
Figure 39. Mexico Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Hyperammonemia Medication Market Share by Country (2021–2032)
Figure 43. Israel Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Hyperammonemia Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Horizon Pharma Revenue Growth Rate in Hyperammonemia Medication Business (2021–2026)
Figure 47. Lee's Pharmaceutical Revenue Growth Rate in Hyperammonemia Medication Business (2021–2026)
Figure 48. Medunik Revenue Growth Rate in Hyperammonemia Medication Business (2021–2026)
Figure 49. Sigmapharm Laboratories Revenue Growth Rate in Hyperammonemia Medication Business (2021–2026)
Figure 50. Amgen Revenue Growth Rate in Hyperammonemia Medication Business (2021–2026)
Figure 51. Acer Therapeutics Revenue Growth Rate in Hyperammonemia Medication Business (2021–2026)
Figure 52. Immedica Revenue Growth Rate in Hyperammonemia Medication Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
